Maternal deletion allele of Angiotensin-converting enzyme gene is associated with fetal growth restriction

Pediatr Dev Pathol. 2012 Mar-Apr;15(2):114-7. doi: 10.2350/11-09-1092-OA.1. Epub 2011 Dec 9.

Abstract

To investigate the correlation between maternal and fetal angiotensin-converting enzyme gene insertion or deletion polymorphism and birth size, angiotensin-converting enzyme gene insertion or deletion polymorphisms of 470 Japanese pairs of mothers and infants were genotyped. The relationships between maternal and fetal angiotensin-converting enzyme gene insertion or deletion polymorphisms and birth sizes (weight, length, head circumference, and the incidence of small-for-gestational age status) were analyzed. No relationship between fetal angiotensin-converting enzyme genotype and birth size was observed. In contrast, the incidence of small-for-gestational age status in babies whose mothers had 1 or 2 deletion alleles was greater than that in babies whose mothers had 2 insertion alleles (7% vs 3%, P = 0.045). Maternal deletion allele of angiotensin-converting enzyme is associated with fetal growth restriction in the Japanese normal population.

MeSH terms

  • Alleles
  • Asian People / genetics
  • Birth Weight / genetics*
  • Female
  • Fetal Growth Retardation / genetics*
  • Genotype
  • Humans
  • Infant, Newborn
  • Male
  • Peptidyl-Dipeptidase A / genetics*
  • Polymerase Chain Reaction
  • Polymorphism, Single Nucleotide
  • Pregnancy
  • Sequence Deletion

Substances

  • Peptidyl-Dipeptidase A